Track KLRS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
KLRS - Kalaris Therapeutics, Inc. (KLRS) has a earnings per share of -$0.46, up 81.7% over the past year.
Latest EPS (Actual)
-$0.46
Beat Rate
25.0%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.52 | -$0.46 | Beat | +11.54% |
| Mar 2026 | -$0.55 | -$0.44 | Beat | +20.00% |
| Nov 2025 | -$0.61 | -$0.64 | Meet | -4.92% |
| Aug 2025 | -$0.52 | -$0.61 | Miss | -17.31% |
| May 2025 | -$0.77 | -$2.52 | Miss | -227.27% |
| Feb 2025 | -$0.12 | -$3.28 | Miss | -2633.33% |
| Nov 2024 | -$0.10 | -$0.82 | Miss | -765.58% |
| Aug 2024 | -$0.05 | -$0.05 | Meet | +0.00% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.